VHL and neoplasm: While studying how the loss of PBRM1 impacts ccRCC tumorigenesis in mice, Nargund et al. demonstrated that kidney-specific inactivation of Vhl or Pbrm1 alone did not lead to tumor formation (Nargund et al., 2017).